NCT Number: NCT00097630
ABC Trial: Awakening and Breathing Controlled
The purpose of this study is to determine the impact of a new RN/RRT (Registered Nurse/Registered Respiratory Therapist) directed 2-step protocol to wean patients off of a ventilator. This protocol involves daily attempts to halt sedation (spontaneous awakening trials) combined with daily assessments of patients while they are breathing on their own (spontaneous breathing trials).
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
University of Chicago, Chicago, Illinois, United States
About this study
Unnecessary delays in removing patients from mechanical ventilation increase morbidity, mortality, and cost. According to recently published guidelines, the current standard of care for weaning involves the daily assessment of patients while they are breathing spontaneously, also known as spontaneous breathing trials (SBT). While there are important data to support a daily cessation of sedatives and analgesics to the point of patient awakening, the benefit of combining such a daily spontaneous awakening trial (SAT) and an SBT is not known.
This multi-center, randomized controlled trial will test whether a 2-step process of weaning that combines a daily awakening trial (achieved by stopping all sedatives and narcotics every morning) with a daily spontaneous breathing trial is superior to the current standard of care.
The number of days the patient is able to live off the ventilator is the primary question being studied. The secondary questions include the number of days the patient is in Intensive Care Unit (ICU) and the hospital, the complications associated with being on the ventilator (such as the duration and severity of delirium and coma), and in-hospital and one-year mortality. Also, cognitive, psychological, and functional/quality of life outcomes will be measured at discharge and 3 and 12 months later.
In addition, the study will measure plasma drug levels twice daily on five sequential days within 30 minutes of testing with highly reliable and well validated instruments to measure sedation level (i.e., RASS) and delirium (i.e. CAM-ICU).
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Recently on mechanical ventilation (less than 2 weeks prior to enrollment)
- Require mechanical ventilation for more than 12 hours
- Over 18 years old
- Under the services of medicine, cardiology, and neurology
Exclusion criteria
- Admission after cardiopulmonary arrest
- Inability to obtain informed consent
- Existence of an extubation order at the time of the evaluation
- Dependence upon mechanical ventilation for 2 weeks prior to enrollment
Treatment and study plan
SBT: Spontaneous Breathing Trial
ProcedurePrimary outcomes
-
Ventilator free days
Secondary outcomes
-
Length of stay in the ICU and hospital
-
28-day and 1-year survival
-
Duration of coma and delirium
-
Cognitive function
Time frame: at discharge, 3 months, and 12 months
-
Psychological status
Time frame: at discharge, 3 months, and 12 months
-
Functional status
Time frame: at discharge, 3 months, and 12 months
-
Quality of life
Time frame: at discharge, 3 months, and 12 months
Sponsors and collaborators
Lead sponsor
National Institute on Aging (NIA)
Nih
Collaborators
- St. Thomas Foundation, Tennessee
- Vanderbilt University
Registry information
Official study title
Cognitive Impairment in the ICU: Evaluation and Outcomes
Important dates
- Study start
- 2003
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Nov 25, 2004
- Registry last updated
- Dec 11, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
NCT05929703
Aging, Alzheimer Disease
Orange, California, United States
View Trial DetailsSocial and Cognitive Online Training: the SCOT Project
NCT05023187
Aging, Cognition Disorders
Rovereto, Trento, Italy
View Trial DetailsNon-randomized Clinical Trial on Cognitive Stimulation With Virtual Reality in Patients With Mild Cognitive Impairment
NCT06977815
Aging, Cognition Disorders
Badalona, Barcelona, Spain
View Trial DetailsGlycine Supplementation Improves Cognitive Performance in Mexican Older Adults
NCT07643675
Aging, Cognition Disorders
México, State of Mexico, Mexico
View Trial Details